A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-80
SponsorMayo Clinic
About this trial
The purpose of this study is to collect pancreas fluid from the duodenum using the endoscopic pancreas function collection method in healthy participants after pancreatic stimulation with human secretin.
Eligibility criteria
Qualifiers
Males or non-pregnant females
Age 18-80.
Participants must be in good health based on medical history (ASA Class 3 or below)
Participants must be willing and able to provide informed consent
Disqualifiers
History of any form of pancreatitis and/or other pancreatic diseases (e.g. pancreatic cysts, pancreatic masses).
History of inflammatory bowel disease
History of vagotomy.
History of surgically altered upper gastrointestinal anatomy (e.g. gastric bypass, Billroth I/II)
Trial design
Treatments tested in this trial
- Secretin (human synthetic) - ChiRhoClin
Treatment groups
24 Participants
are divided into 1 treatment groupSponsors and collaborators
Mayo Clinic
Lead sponsor
ChiRhoClin, Inc.
Collaborator
Source ClinicalTrials.gov